1 Division of Newborn Medicine, Department of Pediatrics, The Milton S. Hershey Medical Center, The Pennsylvania State University, Hershey
A total of 292 transcutaneous bilirubin (TcB) measurements were performed in 157 white full-term infants: 157 were obtained from the forehead and 135 from the midsternum. TcB measurements correlated well with serum bilirubin determinations (r = .93, P < .0001). The sensitivity of the test was 100% and the specificity 97%. It was possible to establish guidelines for the TcB measurement which identified all infants whose serum bilirubin concentrations exceeded 12.9 mg/100 ml (221 µmoles/liter) with no false-negative and only five false-positive determinations (3%). The positive predictive value for the TcB measurements was 58%. This implies that, in our population, an infant with a TcB index
24 has a 58% chance of having a serum bilirubin concentration >12.9 mg/100 ml. The negative predictive value was 100%. Thus, a negative test will correctly predict the absence of hyperbilirubinemia in all cases. As these measurements were obtained prospectively in a well-baby population with a prevalence of hyperbilirubinemia (>12.9 mg/100 ml) of 4.5%, the positive predictive value should be applicable to other similar populations and will, in fact, increase in populations with a higher prevalence of hyperbilirubinemia. TcB measurements can be recommended for the identification of significant neonatal jaundice in full-term infants. It is important to recognize, however, that because of potential variations in TcB meters as well as serum bilirubin measurements in different laboratories, each institution should establish its own criteria for the use of this instrument.
This article has been cited by other articles:
![]() |
M. J. Maisels Historical Perspectives: Transcutaneous Bilirubinometry NeoReviews, May 1, 2006; 7(5): e217 - e225. [Full Text] [PDF] |
||||
![]() |
K. Grohmann, M. Roser, B. Rolinski, I. Kadow, C. Muller, A. Goerlach-Graw, M. Nauck, and H. Kuster Bilirubin Measurement for Neonates: Comparison of 9 Frequently Used Methods Pediatrics, April 1, 2006; 117(4): 1174 - 1183. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ip, M. Chung, J. Kulig, R. O'Brien, R. Sege, S. Glicken, M. J. Maisels, J. Lau, and Subcommittee on Hyperbilirubinemia An Evidence-Based Review of Important Issues Concerning Neonatal Hyperbilirubinemia Pediatrics, July 1, 2004; 114(1): e130 - e153. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Maisels, E. M. Ostrea Jr, S. Touch, S. E. Clune, E. Cepeda, E. Kring, K. Gracey, C. Jackson, D. Talbot, and R. Huang Evaluation of a New Transcutaneous Bilirubinometer Pediatrics, June 1, 2004; 113(6): 1628 - 1635. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Engle, G. L. Jackson, D. Sendelbach, D. Manning, and W. H. Frawley Assessment of a Transcutaneous Device in the Evaluation of Neonatal Hyperbilirubinemia in a Primarily Hispanic Population Pediatrics, July 1, 2002; 110(1): 61 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Maisels and E. Kring Transcutaneous Bilirubinometry Decreases the Need for Serum Bilirubin Measurements and Saves Money Pediatrics, April 1, 1997; 99(4): 599 - 599. [Full Text] [PDF] |
||||